Robert Clifford - Coastal Pediat Res

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Interim Safety and Immunogenicity of COVID-19 Omicron BA.1 Variant-Containing Vaccine in Children in the USA: an Open-Label Non-Randomised Phase 3 Trial

Avika Dixit,Richard Bennett,Kashif Ali,Carl Griffin,Robert A. Clifford,Mark Turner, Rosanne Poston,Kelly Hautzinger,Anne Yeakey,Bethany Girard, Wen Zhou,Weiping Deng,Honghong Zhou,Sabine Schnyder Ghamloush,Barbara J. Kuter,Karen Slobod,Jacqueline M. Miller,Frances Priddy,Rituparna Das

LANCET INFECTIOUS DISEASESno. 7 (2024): 687-697

引用0浏览0WOS引用

Interim Safety and Immunogenicity of COVID-19 Omicron-BA.1 Variant-Containing Vaccine in Children

medRxiv (Cold Spring Harbor Laboratory) (2023)

引用0浏览0引用

Evaluation of Mrna-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

New England Journal of Medicineno. 21 (2022): 2011-2023

引用81浏览0WOS引用

Safety of Lubiprostone in Pediatric Patients with Functional Constipation: A Nonrandomized, Open-Label Trial

Sunny Z. Hussain, Barrett Labrum,Shadreck Mareya, Stephen Stripling,Robert Clifford

Journal of pediatric gastroenterology and nutrition（2021）

引用2浏览0WOS引用

Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-blind Study with Long-term Extension

Marc A. Benninga,Sunny Z. Hussain,Manu R. Sood,Samuel Nurko,Paul Hyman,Robert A. Clifford,Molly O'Gorman,Taryn Losch-Beridon,Shadreck Mareya,Peter Lichtlen,Carlo Di Lorenzo

Clinical Gastroenterology and Hepatology（2021）

引用17浏览0WOS引用

Immunogenicity and Safety of Different Schedules of the Meningococcal ABCWY Vaccine, with Assessment of Long-Term Antibody Persistence and Booster Responses – Results from Two Phase 2b Randomized Trials in Adolescents

Timo Vesikari,Jerzy Brzostek,Anitta Ahonen,Marita Paassilta,Ewa Majda-Stanislawska,Leszek Szenborn,Miia Virta,Robert Clifford,Teresa Jackowska,Murray Kimmel, Ilaria Bindi,Pavitra Keshavan,Paola Pedotti,Daniela Toneatto

Human Vaccines & Immunotherapeutics（2021）

引用3浏览0WOS引用

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared with 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Heather L. Platt,David Greenberg,Bruce Tapiero,Robert A. Clifford,Nicola P. Klein,David C. Hurley,Tulin Shekar,Jianing Li,Kim Hurtado,Shu-Chih Su,Katrina M. Nolan,Camilo J. Acosta,Richard D. McFetridge,Kara Bickham,Luwy K. Musey

The Pediatric Infectious Disease Journal（2020）

引用38浏览0WOS引用

Immunogenicity And Safety Of Measles-Mumps-Rubella Vaccine At Two Different Potency Levels Administered To Healthy Children Aged 12-15 Months: A Phase Iii, Randomized, Non-Inferiority Trial The Mmr-161 Study Group

Anitta Ahonen,Andrea Berry,Archana Chatterjee,Robert Clifford,Clemente Diaz Perez,Javier Diez-Domingo, Byron Haney,Christopher J. Harrison,Angkool Phirangkul Kerdpanich, Jimmy K. F. Lee,Michael Leonardi,Federico Martinon-Torres,Mariano Miranda,Xavier Maria Perez Porcuna,Wanatpreeya Phongsamart, Sharifah Engku Alwi Huda,Teck-Hock Toh,Jerry Twiggs, Ulied Angels Arminana,Meera Varman,Edward Zissman,Adrian Caplanusi,Stephane Carryn,Ouzama Henry,Michael Povey

VACCINEno. 38 (2018): 5781-5788

引用0浏览0引用

Su1644 - Long-Term Open-Label Safety Extension Study Assessing Oral Lubiprostone in Children with Pediatric Functional Constipation Aged 6-17 Years

Marc A. Benninga,Robert A. Clifford,Molly O'Gorman,Taryn Losch-Beridon,Shadreck M. Mareya,Carlo Di Lorenzo

GASTROENTEROLOGY（2018）

引用3浏览0引用

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants

Melissa Pavilack,Robert A. Clifford,Tara Gonzales,Amanda M. Kong,Sally Wade,Kimmie K. McLaurin

Infectious Diseases and Therapy（2017）

引用12浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn